Back to top

SUPPLY AND LICENSE AGREEMENT

Requirements Supplier Agreement

SUPPLY AND LICENSE AGREEMENT | Document Parties: AUTOIMMUNE INC | Colloral LLC | Jenasol LLC You are currently viewing:
This Requirements Supplier Agreement involves

AUTOIMMUNE INC | Colloral LLC | Jenasol LLC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: SUPPLY AND LICENSE AGREEMENT
Date: 11/13/2007
Industry: Biotechnology and Drugs     Sector: Healthcare

SUPPLY AND LICENSE AGREEMENT, Parties: autoimmune inc , colloral llc , jenasol llc
50 of the Top 250 law firms use our Products every day

Exhibit 10.1

SUPPLY AND LICENSE AGREEMENT

This Agreement is made effective as of August 20, 2007 by and among Colloral LLC, a Delaware limited liability company (“Colloral”), Bronson Laboratories, LLC a New York limited liability company, Futurebiotics, LLC, a New York limited liability company, and Jenasol LLC, a New York limited liability company.

1. DEFINITIONS

1.1. Bronson Companies means Bronson Laboratories LLC, Futurebiotics, LLC, and Jenasol LLC.

1.2. Bronson Company means any one of the Bronson Companies.

1.3. Bronson Representative means Steve Welling, COO, Futurebiotics, LLC

1.4. Commencement Date means September 1, 2007.

1.5. Confidential Information means business and technical information and other similar information, including, without limitation, the terms of this Agreement, communicated to one party by the other party in any manner in connection with this Agreement, whether before or during the term of this Agreement, but expressly excludes information that: (i) is or becomes generally available to the public, other than as a result of disclosure by the recipient party in violation of this Agreement; (ii) becomes available to the recipient party from a source other than the disclosing party; as long as such source is not itself bound by a confidentiality or non-disclosure agreement with the disclosing party or otherwise prohibited from disclosing such Confidential Information by a legal, contractual or fiduciary obligation; (iii) was rightfully in the recipient party’s possession prior to receipt from the disclosing party; or (iv) is independently developed by the recipient party without the use of the disclosing party’ s Confidential Information.

1.6. Direct Response Channels means direct mail, telemarketing, direct response radio advertising, direct response television advertising, direct response magazine advertising, direct response newspaper advertising, but excludes, without limitation, catalogs and websites.

1.7. Effective Date means the date of this Agreement.

1.8. Futurebiotics Agreements means the Supply and License Agreement by and between Colloral and Futurebiotics, LLC dated effective January 10, 2007 and the Supply and License Agreement by and between Colloral and Futurebiotics, LLC dated effective April 9, 2007.

1.9. Improvements means any findings, discoveries, inventions, additions, patents, know-how, modifications, formulations, or changes that relate to or are incorporated into the Product made during the term of this Agreement. Trademarks are specifically excluded from the definition of Improvements.

 

 


1.10. Intellectual Property means any invention, idea, concept, discovery, design, development, technique, methodology, innovation, process, formula, data, know-how, trade secret, or intellectual property right, writing, documentation, data, computer software and hardware, and related documentation whatsoever, or any interest therein, whether or not patentable or registrable or subject to analogous protection relating to or incorporated in the Product, including, without limitation, any Improvements, whether made by Colloral, its licensors, the Bronson Companies, or any of such parties working together.

1.11. Losses means liabilities; claims, whether asserted by a third party or by a party to this Agreement; losses; damages; judgments; awards; costs; and expenses, including, without limitation, reasonable attorneys’ fees.

1.12. Product means Colloral’s proprietary dietary supplement for the relief of joint pain that Colloral currently markets under the names COLLORAL ® and THE COLLAGEN SOLUTION TM in its current form or any form later developed, as a stand alone product and not in combination with or as a component of other products.

1.13. Territory means the United States of America.

1.14. Website means the website through which Colloral sells the Product under the trademark, THE COLLAGEN SOLUTION, which website is currently located at www.collagensolution.com.

2. LICENSE

2.1. Grant . Subject to the terms and conditions of this Agreement, Colloral hereby grants to the Bronson Companies a non-transferable and non-assignable license to market, offer for sale, and sell the Product, in the Territory, solely through Direct Response Channels. The Bronson Companies hereby covenant that they will use their best efforts to market the Product through Direct Response Channels in the Territory.

2.2. Limited Exclusivity . The license granted to the Bronson Companies hereunder will be exclusive for a period of [****] following the Commencement Date. The exclusivity of the license will extend automatically under the following conditions:

(a) If the Bronson Companies purchase and pay for at least [****] units of Product in the period between the Effective Date and the [****] anniversary of the Commencement Date, the exclusivity will extend to the [****] anniversary of the Commencement Date;

(b) If (i) exclusivity extends through the [****] anniversary of the Commencement Date and (ii) the Bronson Companies purchase and pay for at least [****] units of Product in the period between the [****] anniversary of the Commencement Date and the [****] anniversary of the Commencement Date, the exclusivity will extend to the [****] anniversary of the Commencement Date; and

(c) If (i) this Agreement renews and (ii) the Bronson Companies purchase and pay for at least [****] units of Product in the period between the [****] anniversary of

 

-2-

 


the Commencement Date and the [****] anniversary of the Commencement Date, the exclusivity will extend to the [****] anniversary of the Commencement Date.

If exclusivity renews under Subsection 2.2(c) above, the parties shall negotiate in good faith to set minimums for maintaining exclusivity for the last [****] years of the renewal term, which levels shall in no event be below [****] units.

2.3. No Sublicenses . The Bronson Companies may not sublicense their rights under this Agreement without Colloral’s prior written consent.

(a) Media and Distribution Partnerships . Notwithstanding the restriction on sublicenses above, the Bronson Companies are expressly granted the right to engage third party media and distribution partners to market and distribute the Product on their behalf and under their branding on a market by market basis, but any such engagements must expressly restrict the third parties from marketing or distributing the Product (i) through channels other than Direct Response Channels and (ii) outside the Territory. The Bronson Companies shall be responsible for the actions of such third parties, and any marketing and distribution by such third parties that does not comply with the restrictions in this Agreement, or other Agreements with any of the Bronson Companies shall be deemed a material breach by the Bronson Companies of this Agreement.

(b) Rights to Media and Distribution Partnerships . The Bronson Companies shall provide notice to Colloral identifying the third party media and distribution partners it uses. Colloral shall not work with those parties to distribute Product in the Territory and shall not encourage such parties to cease working with the Bronson Companies or to work with others to distribute Product in the Territory.

2.4. Retention of Rights . Colloral retains all rights not expressly granted to the Bronson Companies hereunder, including, without limitation, the right to market, offer for sale, and sell (a) its proprietary dietary supplement for the relief of joint pain that it currently markets under the names COLLORAL ® and THE COLLAGEN SOLUTION TM , in its current form or any form later developed, in combination with or as a component of other products and (b) subject to the Futurebiotics Agreements, the Product through any channels and in any territory not expressly covered by the license granted to the Bronson Companies under this Agreement. Colloral may license third parties to exercise its retained rights.

3. MARKETING EFFORTS

3.1. Catalog . The Product shall be included as an offering in the Bronson Companies’ September 2007 catalogs.

3.2. Test of Concept . On or before the first anniversary of the Commencement Date:

(a) The Bronson Companies shall send a minimum of [****] e-mail solicitations offering the Product for sale.

(b) The Bronson Companies shall feature the Product in at least [****] copies of its newsletters, whether distributed electronically or in hard copy.

 

-3-

 


(c) The Bronson Companies shall mail at least [****] catalogs that include the Product as an offering.

(d) The Bronson Companies shall include the Product as an offering in at least [****] inserts that are included in packages of products shipped to the Bronson Companies’ customers.

4. TRADEMARKS

4.1. The Bronson Companies . The Bronson Companies may not market, offer for sale, or sell the Product under the trademarks, COLLORAL or THE COLLAGEN SOLUTION, or as a generic version of such products. The Bronson Companies shall develop, and identify the Product by, their own trademarks.

4.2. Brand Protection . Colloral may not identify the Product as marketed under its trademarks as being the same as the Product as marketed under the Bronson Companies’ trademarks, nor may it make comparisons between the Product as marketed under its trademarks as being the same as the Product as marketed under the Bronson Companies’ trademarks, and the Bronson Companies may not identify the Product as marketed under their trademarks as being the same as the Product as marketed under Colloral’s trademarks, nor may they make comparisons between the Product as marketed under their trademarks as being the same as the Product as marketed under Colloral’s trademarks. Colloral covenants that it will use commercially reasonable efforts to prevent any other person to whom it licenses the right to market and sell the Product from identifying the Product as being the same as the Product marketed by the Bronson Companies and from making comparisons between the Product as marketed by the licensee and the Product as marketed by the Bronson Companies. In no event, however, shall Colloral be required to restrict or prevent another licensee from identifying the origin of the Product.

5. SUPPLY

5.1. Basic Arrangement . Colloral shall manufacture, package, label, pack for shipment, and tender to carriers, and the Bronson Companies shall purchase from Colloral, the Product in bulk, packaged in bottles or other appropriate packaging containing either a [****],[****], or [****] supply, pursuant to purchase orders submitted by the Bronson Companies to Colloral from time to time.

5.2. Colloral Responsibilities . Colloral shall be responsible for purchasing or providing all raw materials and packaging, labor, utilities, and equipment necessary to manufacture the Product and for packing the Product for shipment.

5.3. The Bronson Companies’ Responsibilities . Each of the Bronson Companies shall be responsible for supplying its own labels. If Colloral does not have sufficient labels for a particular order, it may delay shipment of the entire order until the applicable Bronson Company provides the necessary labels. Each Bronson Company shall be responsible (i) for obtaining all required permits and licenses and complying with all applicable laws, regulations, rules, ordinances, licensing and registration requirements, export and import restrictions, and anything

 

-4-

 


else necessary for it to market and sell the Product in the Territory and (ii) for the costs associated therewith.

5.4. Three-Month Rolling Forecast; Scheduling . Each of the Bronson Companies shall provide to Colloral a non-binding rolling three-month forecast of anticipated orders prior to the beginning of each calendar month. Colloral shall use commercially reasonable efforts to ensure that it can ship each order placed by the Bronson Companies under this Agreement within six weeks of the date it receives the order.

5.5. Shipment . All sales of Product under this Agreement shall be by refrigerated truck, F.O.B. St. George, Utah. Title to, and risk of loss of, Product shall be transferred to the applicable Bronson Company by Colloral upon tender by Colloral to such Bronson Company’s designated carrier. In the event that Colloral desires to tender the Product to carriers at a location other than St. George, Utah, Colloral shall notify the Bronson Representative at least 30 days prior to effecting such change, and the Bronson Representative shall have the right to object to the change. If the Bronson Representative does not object to the new location within such 30-day period or if the Bronson Representative affirmatively indicates its approval, Product shall be shipped F.O.B. the new location.

5.6. Certificates of Analysis . Each shipment of Product will be certified by the manufacturer for compliance with Product specifications including potency and purity of finished product. The form of certificate is attached hereto as Schedule A .

5.7. Technical Resource . Colloral shall respond promptly to any reasonable, technical questions posed by the Bronson Companies on behalf of their customers and their customers’ customers, provided, however, than in no event shall Colloral be required to disclose any Confidential Information.

5.8. Exclusivity . The Bronson Companies may not purchase the Product from any person or entity other than Colloral.

5.9. Annual Review . The Bronson Companies shall schedule a meeting between the parties during the last three months of each year of the Term to review sales of the Product to date, forecasts for the coming year and the Bronson Companies’ sales and marketing activities.

5.10. Price and Payment Terms . The Bronson Companies shall pay to Colloral the prices described on Schedule B in U.S. dollars. The Bronson Companies shall be responsible for all sales and use taxes and for all other taxes and charges applicable to the sale of Product to or by the Bronson Companies, other than taxes on Colloral ‘s income. Colloral shall issue invoices for Products shipped to the Bronson Companies on or promptly following the date the Products are tendered to the carrier. The Bronson Companies shall pay Colloral for Product orders within 30 days from the date of shipment of the particular order. If an invoice is not paid within the applicable period, the overdue amount shall bear interest from the date that it was due at the rate of [****]% per annum or, if lower, the highest rate permitted by law.

6. TERM; TERMINATION

 

-5-

 


6.1. Term . The term of this Agreement shall commence as of the Effective Date and shall remain in effect until the third anniversary of the Commencement Date, unless otherwise terminated as set forth below. The Bronson Companies shall have the option to renew this Agreement for one additional three-year term if the Bronson Companies purchased and paid for at least 150,000 units in the period between the second anniversary of the Commencement Date and the third anniversary of the Commencement Date. The Bronson Companies may exercise their option to renew by the Bronson Representative providing notice of exercise to Colloral at least 60 days prior to the third anniversary of the Commencement Date.

6.2. Termination . Colloral may terminate this Agreement by giving notice to the Bronson Representative under any of the following circumstances:

(a) If any of the Bronson Companies fails to perform or comply in any material respect with any of its obligations under this Agreement (except pursuant to a force majeure event set forth in Section 14.2) and such failure is not remedied within 30 days after receipt of notice of such failure;

(b) If any of the Bronson Companies (i) is unable to pay, or admits in writing its inability to pay, its debts as they mature; (ii) makes a general assignment for the benefit of creditors; (iii) applies for or consents to the appointment of a receiver, trustee, or liquidator of all or a substantial par


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more